Skip to main content
FDCT
OTC Technology

FDCTech Restates 2024-2025 Financials, Discloses Material Weaknesses in Internal Controls

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$0.061
Mkt Cap
$25.808M
52W Low
$0.001
52W High
$0.115
52W Position
Off High info
47% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

Summary

FDCTech filed an amended 10-K, restating its 2024 and 2025 financial statements due to errors and disclosing multiple material weaknesses in internal controls over financial reporting, following a non-reliance notice on prior reports.


Key Events · Corporate Governance and Compliance · FDCT

  • Financial Restatement and Non-Reliance

    FDCTech restated its financial statements for fiscal years ended December 31, 2025, and December 31, 2024, due to errors, following a non-reliance notice on prior reports.

  • Material Weaknesses in Internal Controls

    Management identified critical deficiencies in internal controls over financial reporting, including segregation of duties, lack of written policies, insufficient U.S. GAAP expertise, and weak related party transaction controls.

  • Significant Reduction in 2024 Stockholders' Equity

    The 2024 restatement resulted in a $7.97 million reduction in total stockholders' equity, reclassifying an $8.2 million subscription receivable from an asset to contra-equity.

  • Auditor Change Due to 'Prohibited Service Provider' Status

    The previous auditor, Olayinka Oyebola & Co., was dismissed on April 3, 2025, after being designated a 'Prohibited Service Provider' by OTC Markets Group, leading to a reaudit by the new firm, LAO Professionals.


Analysis · FDCT · Technology

FDCTech filed an amended annual report, restating its financial statements for fiscal years 2024 and 2025. This restatement follows a non-reliance notice on previously issued financial reports due to identified errors. The company also disclosed multiple material weaknesses in its internal controls over financial reporting, including issues with segregation of duties, lack of written policies, insufficient GAAP expertise, and inadequate controls over related party transactions. The 2024 restatement significantly reduced total stockholders' equity by $7.97 million, reclassifying an $8.2 million subscription receivable from an asset to contra-equity. This indicates severe deficiencies in financial reporting and governance, which are critical concerns for investors. The previous auditor was dismissed due to being a 'Prohibited Service Provider,' further highlighting the company's historical accounting challenges. While management asserts the company can continue as a going concern and outlines strategic growth plans, the magnitude of these financial and control issues presents substantial risk.

At the time of this filing, FDCT was trading at $0.06 on OTC in the Technology sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $0.00 to $0.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FDCT - Latest Insights

FDCT
Jun 23, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.034
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 23, 2026, 4:37 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $0.034
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:30 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:28 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info